AptarGroup reported an 8% increase in sales to $759 million with a 2% increase in core sales during Q3 2020. The Pharma segment showed strong growth, while Beauty and Beverage segments were impacted by COVID-19. Earnings per share increased to $0.95, and adjusted earnings per share rose to $1.00.
Reported sales increased 8%, including positive effects of currency translation rates and recent acquisitions, and core sales increased 2%.
Strong reported and core growth in the Pharma segment.
Core sales growth in the food, personal care and home care markets.
Reported earnings per share totaled $0.95 (an increase of 12% compared to the prior year), and adjusted earnings per share totaled $1.00 (an increase of 3% compared to the prior year).
Aptar expects to continue to achieve core sales growth in the fourth quarter, with rising demand in many end markets expected to more than offset COVID-19 related declines in some other end markets. Aptar expects earnings per share for the fourth quarter of 2020, excluding any restructuring expenses and acquisition-related costs, to be in the range of $0.84 to $0.92.
Visualization of income flow from segment revenue to net income